InsidersTradesSigma
Discover the complete record of transactions filed by Kaplan Matthew L., 董事. Director active across 1 company, notably Nuvectis Pharma, Inc.. Aggregated, 1 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €18k. History available since 12 May 2022. The latest transaction was disclosed on 12 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Matthew L. Kaplan is a Board Member at Nuvectis Pharma, Inc. In this role, he participates in the company's strategy and governance, ensuring that decisions align with shareholder objectives. His expertise is valuable for the company's development.